# RISE THERAPEUTICS, LLC: A Novel Immunological-Directed Probiotic for the Treatment of Sjögren’s Syndrome

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | RISE THERAPEUTICS, LLC |
| Location | Rockville, MD |
| Project | A Novel Immunological-Directed Probiotic for the Treatment of Sjögren’s Syndrome |
| Project number | 4UH3DE034134-02 |
| Mechanism | UH3 |
| Institute | National Institute of Dental and Craniofacial Research |
| Award | $549,833 |
| Awarded | 2026-09-01 |
| Project period | 2025-08-14 to 2029-08-13 |
| UEI | N36JMJ1DKWH6 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11575646). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.